Infective endocarditis is a grave medical condition marked by inflammation in the inner lining of the heart chambers and valves, known as the endocardium. The inflammation is commonly initiated by the intrusion of bacteria or other infectious agents into the bloodstream, ultimately reaching the heart. The onset of infective endocarditis can be acute or gradual, with symptoms encompassing fever, fatigue, shortness of breath, and an overall sense of malaise. Individuals with pre-existing heart conditions, including congenital heart defects or prosthetic heart valves, face an elevated risk of developing infective endocarditis. Diagnosis necessitates a comprehensive approach, involving clinical assessment, blood tests, and imaging studies to ensure accuracy. Timely identification is imperative, as untreated infective endocarditis can lead to severe complications such as heart valve damage, heart failure, and the formation of infected masses within the heart chambers, known as vegetations.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt